TrialBlood advances2018

Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia.

Anthony S Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.